Literature DB >> 10428846

The molecular assembly of ATP-sensitive potassium channels. Determinants on the pore forming subunit.

J P Giblin1, J L Leaney, A Tinker.   

Abstract

ATP-sensitive potassium channels form a link between membrane excitability and cellular metabolism. These channels are important in physiological processes such as insulin release and they are an important site of drug action. They are an octomeric complex comprised of four sulfonylurea receptors, a member of the ATP-binding cassette family of proteins, and four Kir 6.0 subunits from the inward rectifier family of potassium channels. We have investigated the nature of the interaction between SUR1 and Kir 6.2 and the domains on the channel responsible for the biochemical and functional manifestations of coupling. The results point to the proximal C terminus determining biochemical interaction in a region that also largely governs homotypic and heterotypic interaction between different Kir family members. While this domain may be necessary for functional communication between the two proteins, it is not sufficient since relative modifications of either the N or C terminus are able to disrupt many aspects of functional coupling mediated by the sulfonylurea receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428846     DOI: 10.1074/jbc.274.32.22652

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Agonist unbinding from receptor dictates the nature of deactivation kinetics of G protein-gated K+ channels.

Authors:  Amy Benians; Joanne L Leaney; Andrew Tinker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

2.  Molecular analysis of the subtype-selective inhibition of cloned KATP channels by PNU-37883A.

Authors:  H Kovalev; J M Quayle; T Kamishima; D Lodwick
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

3.  3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1.

Authors:  Michael V Mikhailov; Jeff D Campbell; Heidi de Wet; Kenju Shimomura; Brittany Zadek; Richard F Collins; Mark S P Sansom; Robert C Ford; Frances M Ashcroft
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

4.  Targeted expression of Kir6.2 in mitochondria confers protection against hypoxic stress.

Authors:  Marko Ljubkovic; Jasna Marinovic; Andreas Fuchs; Zeljko J Bosnjak; Martin Bienengraeber
Journal:  J Physiol       Date:  2006-09-07       Impact factor: 5.182

5.  Mutations in the linker domain of NBD2 of SUR inhibit transduction but not nucleotide binding.

Authors:  Michinori Matsuo; Michael Dabrowski; Kazumitsu Ueda; Frances M Ashcroft
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

6.  Direct observation of individual KCNQ1 potassium channels reveals their distinctive diffusive behavior.

Authors:  Gregory I Mashanov; Muriel Nobles; Stephen C Harmer; Justin E Molloy; Andrew Tinker
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

7.  Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.

Authors:  Richard D Rainbow; Marian James; Diane Hudman; Mohammed Al Johi; Harprit Singh; Peter J Watson; Ian Ashmole; Noel W Davies; David Lodwick; Robert I Norman
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

8.  Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.

Authors:  Yi Cui; Andrew Tinker; Lucie H Clapp
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  Effect of metabolic inhibition on glimepiride block of native and cloned cardiac sarcolemmal K(ATP) channels.

Authors:  C L Lawrence; R D Rainbow; N W Davies; N B Standen
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

10.  Inhibitors of ATP-sensitive potassium channels in guinea pig isolated ischemic hearts.

Authors:  A Weyermann; H Vollert; A E Busch; M Bleich; H Gögelein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-03-16       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.